Hot topics

why_foreign_drug_pricing_policies_dont_work_300x170_0.jpg
Reasons to Reject H.R. 3
Making sure that medicines are accessible and affordable for…
Reasons to Reject H.R. 3
How We’re Partnering to Improve Health Outcomes for Black Youth
How We’re Partnering to Improve Health Outcomes for Black Youth
A conversation with Dr. Clyde Glenn, President of the Essie B.…
We’re Partnering to Improve…
why_foreign_drug_pricing_policies_dont_work_300x170.jpg
Why Foreign Drug Pricing Policies Don’t Work
Congress is considering passing a drug pricing policy that could…
Why Foreign Drug Pricing Policies…
Through Public-Private Partnership, Scientists are Working to Better Understand Gene Therapy and How it Could Help Patients With Rare Diseases
Through Public-Private Partnership, Scientists are Working to Better Understand Gene Therapy and How it Could Help Patients With Rare Diseases
A rare disease is, by its very nature, rare.
A Gene Therapy and Rare Diseases…
Aiming for Equity: Assessing Pfizer's Ongoing Commitment to Diversity and Inclusion
Aiming for Equity: Assessing Pfizer's Ongoing Commitment to Diversity and Inclusion
As one of the world’s most prominent biopharmaceutical…
Pfizer's Ongoing Commitment to…
iStock-1199449498_380x300[1].jpg
Increased Access to Biosimilars Could Save the U.S. Healthcare System Billions
Now more than ever, with healthcare costs on the rise, we need…
Increased Access to Biosimilars…
Accumulus_Synergy_380x300.png
How 10 Biopharma Companies are Working Together to Bring Medicines to Patients Faster
In the year since the pandemic struck, the world has watched one…
Accumulus Synergy Brings 10…
Making a Global Impact in Breast Cancer Care
Making a Global Impact in Breast Cancer Care
Every year, more than 2.1 million people around the world are…
Making a Global Impact in Breast…
Doing Better: Increasing Diversity in Clinical Trials
Doing Better: Increasing Diversity in Clinical Trials
Diversity in clinical trials is key to equitable health outcomes.
Doing Better: How Pfizer Will…